HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Li Selected Research

Ammonium Compounds

10/2021Nitrate mediated resistance against Fusarium infection in cucumber plants acts via photorespiration.
4/2017Nitrate increases ethylene production and aerenchyma formation in roots of lowland rice plants under water stress.
9/2015Brief Report: Human Mesenchymal Stem-Like Cells Facilitate Floating Tumorigenic Cell Growth via Glutamine-Ammonium Cycle.
5/2012Chloroplast downsizing under nitrate nutrition restrained mesophyll conductance and photosynthesis in rice (Oryza sativa L.) under drought conditions.
3/2012Drought-induced root aerenchyma formation restricts water uptake in rice seedlings supplied with nitrate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Li Research Topics

Disease

544Neoplasms (Cancer)
10/2022 - 03/2002
131Neoplasm Metastasis (Metastasis)
12/2022 - 05/2003
110Inflammation (Inflammations)
06/2022 - 03/2007
103Stomach Neoplasms (Stomach Cancer)
06/2022 - 04/2002
73Hepatocellular Carcinoma (Hepatoma)
05/2022 - 12/2002
59Fibrosis (Cirrhosis)
05/2022 - 08/2003
57Breast Neoplasms (Breast Cancer)
05/2022 - 05/2003
53Infections
06/2022 - 08/2002
53Carcinogenesis
05/2022 - 03/2004
49Body Weight (Weight, Body)
06/2022 - 06/2003
45Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2003
44Hypoxia (Hypoxemia)
07/2022 - 08/2006
44Lung Neoplasms (Lung Cancer)
06/2022 - 10/2004
40Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 10/2009
37Carcinoma (Carcinomatosis)
08/2021 - 09/2003
34Wounds and Injuries (Trauma)
02/2022 - 02/2003
33Ischemia
06/2022 - 09/2010
33Adenocarcinoma
02/2022 - 02/2005
31Nasopharyngeal Carcinoma
06/2022 - 01/2013
31Hypertension (High Blood Pressure)
01/2022 - 02/2008
30Type 2 Diabetes Mellitus (MODY)
05/2022 - 10/2002
30Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 01/2009
27Insulin Resistance
01/2022 - 05/2007
26Lymphatic Metastasis
10/2020 - 05/2003
24Atherosclerosis
05/2022 - 04/2008
24Reperfusion Injury
01/2022 - 02/2009
23Necrosis
12/2022 - 02/2009
23Brain Injuries (Brain Injury)
06/2022 - 01/2012
21Pain (Aches)
07/2022 - 02/2006
20Esophageal Squamous Cell Carcinoma
07/2022 - 03/2011
20Sepsis (Septicemia)
01/2021 - 12/2010
19Myocardial Infarction
05/2022 - 03/2011
19Melanoma (Melanoma, Malignant)
01/2022 - 03/2002
17Heart Failure
06/2022 - 07/2010
17Hemorrhage
05/2022 - 04/2010
17Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2022 - 11/2012
17Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2007
17Lung Injury
01/2021 - 09/2013
16Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2006
16Cicatrix (Scar)
11/2020 - 05/2003
15Liver Neoplasms (Liver Cancer)
01/2022 - 12/2002
15Myocardial Ischemia (Ischemic Heart Diseases)
07/2021 - 07/2010
15Brain Ischemia (Cerebral Ischemia)
01/2021 - 01/2012
14Acquired Immunodeficiency Syndrome (AIDS)
12/2022 - 03/2010
14Hypersensitivity (Allergy)
05/2022 - 12/2008
14Poisoning
04/2022 - 09/2009
14Disease Progression
01/2022 - 11/2010

Drug/Important Bio-Agent (IBA)

216Proteins (Proteins, Gene)FDA Link
11/2022 - 03/2002
134Biomarkers (Surrogate Marker)IBA
07/2022 - 05/2003
98MicroRNAs (MicroRNA)IBA
06/2022 - 03/2009
69Biological ProductsIBA
03/2022 - 02/2003
67Pharmaceutical PreparationsIBA
05/2022 - 10/2004
67Long Noncoding RNAIBA
01/2022 - 01/2014
54CytokinesIBA
12/2022 - 09/2003
52Messenger RNA (mRNA)IBA
01/2022 - 11/2002
44Glucose (Dextrose)FDA LinkGeneric
05/2022 - 01/2008
37RNA (Ribonucleic Acid)IBA
05/2022 - 12/2005
35AntigensIBA
09/2022 - 03/2002
35Peptides (Polypeptides)IBA
06/2022 - 03/2002
34LipidsIBA
11/2022 - 03/2002
34CollagenIBA
01/2022 - 05/2005
30Therapeutic UsesIBA
03/2022 - 02/2008
27Small Interfering RNA (siRNA)IBA
06/2022 - 10/2010
27DNA (Deoxyribonucleic Acid)IBA
03/2022 - 09/2003
25Interleukin-6 (Interleukin 6)IBA
06/2022 - 04/2009
25EnzymesIBA
01/2022 - 02/2005
23CholesterolIBA
05/2021 - 06/2003
21Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 01/2013
21Blood Glucose (Blood Sugar)IBA
05/2022 - 03/2010
21Insulin (Novolin)FDA Link
01/2021 - 08/2004
20LigandsIBA
10/2021 - 06/2007
18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 10/2009
18Indicators and Reagents (Reagents)IBA
05/2022 - 06/2007
18AntioxidantsIBA
03/2022 - 08/2010
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 02/2006
18Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2010
17AntibodiesIBA
06/2022 - 05/2004
17Neuroprotective AgentsIBA
01/2022 - 12/2009
17Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2011
17Matrix Metalloproteinases (MMPs)IBA
01/2022 - 09/2008
17oxidized low density lipoproteinIBA
10/2021 - 12/2007
15VaccinesIBA
09/2022 - 07/2002
15Circular RNAIBA
09/2022 - 01/2017
15Phosphotransferases (Kinase)IBA
01/2022 - 04/2003
15Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
15ErbB Receptors (EGF Receptor)IBA
01/2022 - 12/2008
14LipopolysaccharidesIBA
05/2022 - 04/2005
14CateninsIBA
03/2022 - 12/2013
14ORALIT (ORS)IBA
01/2022 - 01/2015
14Ethanol (Ethyl Alcohol)IBA
06/2021 - 09/2005
13C-Reactive ProteinIBA
06/2022 - 04/2010
13Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2022 - 08/2010

Therapy/Procedure

207Therapeutics
11/2022 - 10/2002
60Drug Therapy (Chemotherapy)
07/2022 - 10/2004
42Immunotherapy
06/2022 - 03/2002
37Radiotherapy
12/2022 - 11/2012
27Gastrectomy
06/2022 - 02/2008
27Neoadjuvant Therapy
03/2022 - 05/2013
18Ligation
05/2022 - 12/2010
16Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 12/2011